Interview with Alberto Sobrero,MD, PhD about the results of a phase III study of aflibercept versus placebo in combination with Folfiri for the treatment of patients with previously treated metastatic colorectal cancer (VELOUR). Interview by the European Society for Medical Oncology (ESMO).
Link to this comment:
All Comments (0)